Current Insights into Combination Therapies with MAPK Inhibitors and Immune Checkpoint Blockade

The recent development of high-throughput genomics has revolutionized personalized medicine by identifying key pathways and molecular targets controlling tumor progression and survival. Mitogen-activated protein kinase (MAPK) pathways are examples of such targets, and inhibitors against these pathwa...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Min Hwa, Kim, Jiyoung, Lim, Siyoung A., Kim, Jeongsoo, Lee, Kyung-Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177307/
https://www.ncbi.nlm.nih.gov/pubmed/32260561
http://dx.doi.org/10.3390/ijms21072531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177307/
https://www.ncbi.nlm.nih.gov/pubmed/32260561
http://dx.doi.org/10.3390/ijms21072531

Ejemplares similares